1
1

PILLS Act

6/3/2025, 4:23 AM

Summary of Bill S 1891

The bill titled "A bill to amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes" was introduced in the 119th Congress on May 22, 2025. The bill aims to create a production credit specifically for generic drugs and biosimilars within the Internal Revenue Code of 1986, along with other related purposes.

Current Status of Bill S 1891

Bill S 1891 is currently in the status of Bill Introduced since May 22, 2025. Bill S 1891 was introduced during Congress 119 and was introduced to the Senate on May 22, 2025.  Bill S 1891's most recent activity was Read twice and referred to the Committee on Finance. as of May 22, 2025

Bipartisan Support of Bill S 1891

Total Number of Sponsors
2
Democrat Sponsors
0
Republican Sponsors
2
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 1891

Primary Policy Focus

Alternate Title(s) of Bill S 1891

PILLS Act
PILLS Act
Producing Incentives for Long-term production of Lifesaving Supply of medicine Act
A bill to amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.

Comments